Yahoo Finance

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator ...
Benzinga.com

MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations

Health Canada licensed psychedelics producer Optimi Health Corp. OPTHF has completed the first batch of its proprietary pre-clinical MDMA drug candidate to be used in drug development, clinical trials ...
Financial Post

Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video

VANCOUVER, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and ...
Nasdaq

Optimi Health Secures Key Licence for Psychedelic Treatments

Optimi Health (TSE:OPTI) has released an update. Optimi Health Corp. has received a Drug Establishment Licence from Health Canada, enabling the company to manufacture and sell GMP-compliant MDMA and ...
Digital Journal

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

Optimi CEO, Bill Ciprick, expressed his enthusiasm about Optimi’s progress in natural extraction techniques, saying, "The establishment of new intellectual property always represents a significant ...
Mena FN

Optimi Completes Proprietary Natural Psilocybin Extraction Process And Files U.S. Provisional Patent

(MENAFN- GlobeNewsWire - Nasdaq) VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi ...